Phytomedicine
Volume 17, Issue 13 , Pages 1016-1026, November 2010

Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril

  • S.M. Asdaq

      Affiliations

    • Department of Phaarmacology, Krupanidhi College of Pharmacy, Varthur Hobli, Chikkabellandur Village, Carmalaram Post, Bangalore 560 035, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 80 65973260; fax: +91 80 51309161.
  • ,
  • M.N. Inamdar

      Affiliations

    • Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore 560 027, India

published online 26 August 2010.

Abstract 

The purpose of the present study was to investigate the role of fresh garlic homogenate (FGH) and its bioactive sulphur compound S-allyl cysteine sulphoxide (SACS) in potentiating antihypertensive and cardioprotective activities of captopril in rats. SACS was extracted from the fresh garlic using ion exchange resins with yield of 890mg/kg garlic. The dose of SACS was calculated based on the amount of SACS extracted from 125 to 250mg of FGH. Albino rats weighing 150–200g were fed with 10% fructose in fluid for 3 weeks for induction of hypertension and subsequently administered FGH (125 and 250mg/kg, p.o.) or SACS (0.111 and 0.222mg/kg/day, p.o.) for the next 3 weeks in their respective groups. In CAP alone and interactive groups (GH+CAP; SACS+CAP), captopril 30mg/kg was given during sixth week of 10% fructose in fluid. At the end of drug treatment, animals were given isoproterenol 175mg/kg subcutaneously for two consecutive days. Additionally, varying concentrations of SACS (4, 8, 16, 32 and 64ng), CAP (1, 2, 4, 8 and 16ng) and their combination (4:1) were checked for fall in blood pressure in hypertensive rats (10% fructose in fluid without pretreatment) as well as angiotensin-converting enzyme (ACE) inhibiting activity using guinea pig ileum. An isobolographic analysis was used to characterise the interaction between SACS and CAP for fall in blood pressure and ACE inhibiting evaluations. Administration of captopril, low and high doses of FGH (125, 250mg/kg), either alone or together showed fall in fluid intake and body weight. The combined therapy of FGH 250mg/kg and CAP was more effective in reducing systolic blood pressure, cholesterol, triglycerides and glucose. The SOD and catalase activities in heart tissue were significantly elevated in groups treated with FGH, SACS, CAP, FGH+CAP and SACS+CAP. Further, combined therapy of FGH 250mg/kg and CAP caused significant fall in LDH and CK-MB activities in serum and elevation in heart tissue homogenate. SACS in low dose was less effective than low dose of FGH; similarly, high dose of FGH was more efficacious than high dose of SACS. Corroborating with this, combined therapy of garlic (250mg/kg) with CAP demonstrated higher synergistic action than combination of SACS (0.222mg/kg) with CAP suggesting the role of additional bioactive constituents apart from SACS, responsible for therapeutic efficacy of garlic. Moreover, combination of SACS and CAP exerted super-additive (synergistic) interaction with respect to fall in blood pressure and ACE inhibition. This study may represent an advertence on concomitant use of garlic or its bioactive constituent, SACS, with captopril.

Keywords: ACE inhibition, Captopril, Garlic, Interaction, Isobolographic analysis, S-allyl cysteine sulphoxide, Synergy effect

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0944-7113(10)00234-5

doi:10.1016/j.phymed.2010.07.012

Phytomedicine
Volume 17, Issue 13 , Pages 1016-1026, November 2010